Re: SGEN SGN-CD33A AML trial clinical hold I assume that the full clinical hold was placed on transplant eligible patients as these patients are more vulnerable either pre or post ASCT.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.